GlassScriptPhysician profile
Carl A Freeman
NPI 1629172846
$7,222.35
in general payments reported to CMS, 2019-2025
25 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $407 · 2021: $130 · 2022: $2,028 · 2023: $2,157 · 2024: $1,641 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,507 · Food and Beverage: $1,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,506.59 |
| Food and Beverage | $1,720.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $4,445.68 | 2022-2024 | |
| Acera Surgical, INC. | $445.31 | 2023-2025 | Restrata Wound Matrix |
| Kci USA, INC. | $384.38 | 2019-2021 | |
| Davol INC. | $379.32 | 2019-2023 | Phasix Mesh |
| Kerecis Limited | $279.84 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $182.65 | 2022-2025 | Matrixrib |
| Zimmer Biomet Holdings, INC. | $150.95 | 2021-2025 | Sternalock Blu System |
| Integra Lifesciences Corporation | $149.88 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Acell, INC. | $108.67 | 2019 | |
| W. L. Gore & Associates, INC. | $99.79 | 2021-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Medtronic, INC. | $89.29 | 2022 | |
| Polynovo North America LLC | $71.50 | 2021 | |
| Veryan Medical Incorporated | $58.74 | 2022 | |
| Solventum Corporation | $56.47 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Clr Medical, INC. | $55.00 | 2024 | Irrigator |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $53.31 | 2023 | Irrisept |
| Ethicon US, LLC | $52.73 | 2019-2023 | Monocryl |
| Dilon Technologies, INC. | $27.54 | 2025 | Hemoblast Bellows |
| Avita Medical Americas, LLC | $24.89 | 2025 | Cohealyx, Recell, Permeaderm |
| Aroa Biosurgery Incorporated | $24.85 | 2025 | |
| Haemonetics Corporation | $24.59 | 2022 | |
| Smith+Nephew, INC. | $24.25 | 2022 | |
| Atricure, INC. | $17.43 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Teleflex LLC | $15.29 | 2024 | Quikclot |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.